Thor Equities Expands Life Sciences Footprint
The firm has launched a new life sciences platform and has acquired a $152M life sciences campus in New Jersey.
NEW YORK–Thor Equities has launched Thor Sciences, a new division to focus on the Life Sciences sector.
Thor Equities has also announced the acquisition of The Center of Excellence, a 784,000-square-foot campus across 48 acres in Bridgewater, NJ for $152 million. The campus is comprised of laboratory, research and development and office buildings, which hosts life science companies that specialize in pharmaceuticals and health services. Tenants include Nestlé Health Science, Ashland, and Amneal Pharmaceuticals, Insmed, Avantor, Nevakar, Solaris Pharma, Clinical Genomics, Matinas BioPharma, Vertice Pharma, 3D Biotek, Unionmed Tech and GSG Scientific.
Thor Equities plans to implement a multimillion dollar expansion to the center.
Bill Hunter has been appointed to senior vice president of Thor Sciences. Hunter holds more than twenty years of experience in the industry, and was instrumental in acquiring The Center of Excellence and unveiling Thor’s global platform. He has executed more than 10.5 million square feet in industry acquisitions totaling $4 billion.
Thor Equities is a global real estate development, leasing and management company that focuses on commercial, office, retail, hotel, residential and mixed-use assets in urban areas.